In the context of inflammatory myopathies, IBM has been associated with a marked increase in CD8+ TEMRA cells, which are known for their resistance to apoptosis, enhanced cytotoxicity and secretion of pro‐inflammatory cytokines.7 The gene discussed is CD8A; the disease is inclusion body myositis.